Pharmaceutical companies AbbVie and Biogen have voluntarily begun the process of removing the drug Zinbryta (daclizumab) from the market worldwide. The drug was intended to treat patients with multiple sclerosis (MS) after other drugs failed to work. It was approved in the U.S. by the Food and Drug Administration (FDA) in 2016 and that agency […]